EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for GH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -3.500
March 31, 2026 -3.400
December 31, 2025 -3.315
September 30, 2025 -3.213
June 30, 2025 -3.346
March 31, 2025 -3.379
December 31, 2024 -3.556
September 30, 2024 -4.237
June 30, 2024 -4.092
March 31, 2024 -3.923
December 31, 2023 -4.279
September 30, 2023 -4.066
June 30, 2023 -4.918
March 31, 2023 -6.498
December 31, 2022 -6.407
September 30, 2022 -5.936
June 30, 2022 -5.412
March 31, 2022 -4.128
December 31, 2021 -4.005
Date Value
September 30, 2021 -4.048
June 30, 2021 -3.768
March 31, 2021 -3.373
December 31, 2020 -2.580
September 30, 2020 -1.911
June 30, 2020 -1.268
March 31, 2020 -0.8294
December 31, 2019 -0.8387
September 30, 2019 -0.8691
June 30, 2019 -1.017
March 31, 2019 -1.140
December 31, 2018 -0.9991
September 30, 2018 -0.8768
June 30, 2018 -0.9262
March 31, 2018 -0.9486
December 31, 2017 -0.9741
September 30, 2017 -0.7978
June 30, 2017 -0.4632
March 31, 2017 -0.1875

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Natera, Inc. -1.368
NeoGenomics, Inc. -0.4034
Quest Diagnostics, Inc. 9.427
Labcorp Holdings, Inc. 12.09
OPKO Health, Inc. -0.0965